대표이사 인사말

안녕하십니까. 

한국유씨비제약 대표이사 에드워드 리(Edward Lee)입니다.

UCB는 ‘환자로부터 영감, 과학을 통한 발전(Inspired by Patients, 
Driven by Science)’이라는 철학을 바탕으로, 
면역학과 신경학 분야에서 혁신적인 치료제를 제공하며 
환자들의 치료 결과와 삶의 질 향상을 위해 
끊임없이 노력하고 있습니다.

한국유씨비제약은 1989년 설립 이래 중증 및 난치성 질환을 
중심으로 환자들의 미충족 의료 수요를 해결하기 위한 
혁신 치료제를 지속적으로 도입하며, 
국내 보건의료 환경 발전에 기여해 왔습니다.

앞으로도 한국유씨비제약은 
과학적 혁신과 환자 중심의 가치를 기반으로, 
국내 보건의료 환경에 긍정적인 변화를 이끄는
신뢰받는 파트너가 되기 위해 최선을 다하겠습니다.

감사합니다. 

한국유씨비제약 대표이사 에드워드 리 (Edward Lee) 

Hello, I am Edward Lee, General Manager of UCB Korea.

Thank you for visiting the UCB Korea website.

At UCB, we are “Inspired by Patients, Driven by Science.” 
Guided by this philosophy, we focus on delivering innovative healthcare solutions across immunology and neurology to optimize patient outcomes and experiences throughout the world. 

Since its establishment in 1989, UCB Korea has been committed to introducing transformative therapies that address unmet needs in severe and refractory diseases, contributing to the advancement of the Korean healthcare environment.

Going forward, UCB Korea will continue to pursue scientific innovation and patient-centered value, striving to be a trusted partner that drives meaningful and positive change in Korea’s healthcare landscape.

Thank you. 

Edward Lee

General Manager, UCB Korea